Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles

Identifieur interne : 000045 ( Hal/Checkpoint ); précédent : 000044; suivant : 000046

Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles

Auteurs : Dominik Dolles [Allemagne] ; Matthias Hoffmann [Allemagne] ; Sandra Gunesch [Allemagne] ; Oliviero Marinelli [Italie] ; Jan Möller [Allemagne] ; Giorgio Santoni [Italie] ; Arnaud Chatonnet [France] ; Martin J. Lohse [Allemagne] ; Hans-Joachim Wittmann [Allemagne] ; Andrea Strasser [Allemagne] ; Massimo Nabissi [Italie] ; Tangui Maurice [France] ; Michael Decker [Allemagne]

Source :

RBID : Hal:hal-01837661

Abstract

The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promisingtargets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE. A homology model for the hCB2R was developed based on the hCB1R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved hCB2R agonism. Unwanted μ-opioid receptor affinitycould be designed out. One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.


Url:
DOI: 10.1021/acs.jmedchem.7b01760

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:hal-01837661

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</title>
<author>
<name sortKey="Dolles, Dominik" sort="Dolles, Dominik" uniqKey="Dolles D" first="Dominik" last="Dolles">Dominik Dolles</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Hoffmann, Matthias" sort="Hoffmann, Matthias" uniqKey="Hoffmann M" first="Matthias" last="Hoffmann">Matthias Hoffmann</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Gunesch, Sandra" sort="Gunesch, Sandra" uniqKey="Gunesch S" first="Sandra" last="Gunesch">Sandra Gunesch</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Marinelli, Oliviero" sort="Marinelli, Oliviero" uniqKey="Marinelli O" first="Oliviero" last="Marinelli">Oliviero Marinelli</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Moller, Jan" sort="Moller, Jan" uniqKey="Moller J" first="Jan" last="Möller">Jan Möller</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539027" status="INCOMING">
<orgName>Institute of Pharmacology and Toxicology</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Santoni, Giorgio" sort="Santoni, Giorgio" uniqKey="Santoni G" first="Giorgio" last="Santoni">Giorgio Santoni</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Chatonnet, Arnaud" sort="Chatonnet, Arnaud" uniqKey="Chatonnet A" first="Arnaud" last="Chatonnet">Arnaud Chatonnet</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-206262" status="OLD">
<idno type="RNSR">199917397U</idno>
<orgName>Dynamique Musculaire et Métabolisme</orgName>
<orgName type="acronym">DMEM</orgName>
<date type="end">2019-12-31</date>
<desc>
<address>
<addrLine>INRA 2 place Viala 34060 Montpellier Cedex 1</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www6.montpellier.inra.fr/dmem/</ref>
</desc>
<listRelation>
<relation name="UMR 0866" active="#struct-410122" type="direct"></relation>
<relation active="#struct-92114" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UMR 0866" active="#struct-410122" type="direct">
<org type="institution" xml:id="struct-410122" status="VALID">
<idno type="ISNI">0000000120970141</idno>
<orgName>Université de Montpellier</orgName>
<orgName type="acronym">UM</orgName>
<desc>
<address>
<addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.umontpellier.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92114" type="direct">
<org type="institution" xml:id="struct-92114" status="OLD">
<orgName>Institut National de la Recherche Agronomique</orgName>
<orgName type="acronym">INRA</orgName>
<date type="start">1946-05-18</date>
<date type="end">2019-12-31</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.inra.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Lohse, Martin J" sort="Lohse, Martin J" uniqKey="Lohse M" first="Martin J." last="Lohse">Martin J. Lohse</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539027" status="INCOMING">
<orgName>Institute of Pharmacology and Toxicology</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Wittmann, Hans Joachim" sort="Wittmann, Hans Joachim" uniqKey="Wittmann H" first="Hans-Joachim" last="Wittmann">Hans-Joachim Wittmann</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539028" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry II, Institute of Pharmacy</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Strasser, Andrea" sort="Strasser, Andrea" uniqKey="Strasser A" first="Andrea" last="Strasser">Andrea Strasser</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539028" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry II, Institute of Pharmacy</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Nabissi, Massimo" sort="Nabissi, Massimo" uniqKey="Nabissi M" first="Massimo" last="Nabissi">Massimo Nabissi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Maurice, Tangui" sort="Maurice, Tangui" uniqKey="Maurice T" first="Tangui" last="Maurice">Tangui Maurice</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3068" status="VALID">
<idno type="RNSR">200716389N</idno>
<orgName>Mécanismes moléculaires dans les démences neurodégénératives</orgName>
<orgName type="acronym">MMDN</orgName>
<desc>
<address>
<addrLine>U1198 - Université de Montpellier, Place Eugène Bataillon 34095 Montpellier Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://mmdn.umontpellier.fr/fr/</ref>
</desc>
<listRelation>
<relation name="U1198" active="#struct-303623" type="direct"></relation>
<relation active="#struct-92690" type="direct"></relation>
<relation name="UMR_S 1198" active="#struct-410122" type="direct"></relation>
<relation active="#struct-110691" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="U1198" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92690" type="direct">
<org type="institution" xml:id="struct-92690" status="OLD">
<orgName>Université Montpellier 2 - Sciences et Techniques</orgName>
<orgName type="acronym">UM2</orgName>
<date type="end">2014-12-31</date>
<desc>
<address>
<addrLine>Place Eugène Bataillon - 34095 Montpellier cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-montp2.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1198" active="#struct-410122" type="direct">
<org type="institution" xml:id="struct-410122" status="VALID">
<idno type="ISNI">0000000120970141</idno>
<orgName>Université de Montpellier</orgName>
<orgName type="acronym">UM</orgName>
<desc>
<address>
<addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.umontpellier.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-110691" type="direct">
<org type="institution" xml:id="struct-110691" status="VALID">
<orgName>École pratique des hautes études</orgName>
<orgName type="acronym">EPHE</orgName>
<desc>
<address>
<addrLine>4-14 Rue Ferrus, 75014 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ephe.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Decker, Michael" sort="Decker, Michael" uniqKey="Decker M" first="Michael" last="Decker">Michael Decker</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01837661</idno>
<idno type="halId">hal-01837661</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01837661</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01837661</idno>
<idno type="doi">10.1021/acs.jmedchem.7b01760</idno>
<date when="2018">2018</date>
<idno type="wicri:Area/Hal/Corpus">000149</idno>
<idno type="wicri:Area/Hal/Curation">000149</idno>
<idno type="wicri:Area/Hal/Checkpoint">000045</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000045</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</title>
<author>
<name sortKey="Dolles, Dominik" sort="Dolles, Dominik" uniqKey="Dolles D" first="Dominik" last="Dolles">Dominik Dolles</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Hoffmann, Matthias" sort="Hoffmann, Matthias" uniqKey="Hoffmann M" first="Matthias" last="Hoffmann">Matthias Hoffmann</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Gunesch, Sandra" sort="Gunesch, Sandra" uniqKey="Gunesch S" first="Sandra" last="Gunesch">Sandra Gunesch</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Marinelli, Oliviero" sort="Marinelli, Oliviero" uniqKey="Marinelli O" first="Oliviero" last="Marinelli">Oliviero Marinelli</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Moller, Jan" sort="Moller, Jan" uniqKey="Moller J" first="Jan" last="Möller">Jan Möller</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539027" status="INCOMING">
<orgName>Institute of Pharmacology and Toxicology</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Santoni, Giorgio" sort="Santoni, Giorgio" uniqKey="Santoni G" first="Giorgio" last="Santoni">Giorgio Santoni</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Chatonnet, Arnaud" sort="Chatonnet, Arnaud" uniqKey="Chatonnet A" first="Arnaud" last="Chatonnet">Arnaud Chatonnet</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-206262" status="OLD">
<idno type="RNSR">199917397U</idno>
<orgName>Dynamique Musculaire et Métabolisme</orgName>
<orgName type="acronym">DMEM</orgName>
<date type="end">2019-12-31</date>
<desc>
<address>
<addrLine>INRA 2 place Viala 34060 Montpellier Cedex 1</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www6.montpellier.inra.fr/dmem/</ref>
</desc>
<listRelation>
<relation name="UMR 0866" active="#struct-410122" type="direct"></relation>
<relation active="#struct-92114" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UMR 0866" active="#struct-410122" type="direct">
<org type="institution" xml:id="struct-410122" status="VALID">
<idno type="ISNI">0000000120970141</idno>
<orgName>Université de Montpellier</orgName>
<orgName type="acronym">UM</orgName>
<desc>
<address>
<addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.umontpellier.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92114" type="direct">
<org type="institution" xml:id="struct-92114" status="OLD">
<orgName>Institut National de la Recherche Agronomique</orgName>
<orgName type="acronym">INRA</orgName>
<date type="start">1946-05-18</date>
<date type="end">2019-12-31</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.inra.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Lohse, Martin J" sort="Lohse, Martin J" uniqKey="Lohse M" first="Martin J." last="Lohse">Martin J. Lohse</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539027" status="INCOMING">
<orgName>Institute of Pharmacology and Toxicology</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Wittmann, Hans Joachim" sort="Wittmann, Hans Joachim" uniqKey="Wittmann H" first="Hans-Joachim" last="Wittmann">Hans-Joachim Wittmann</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539028" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry II, Institute of Pharmacy</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Strasser, Andrea" sort="Strasser, Andrea" uniqKey="Strasser A" first="Andrea" last="Strasser">Andrea Strasser</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539028" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry II, Institute of Pharmacy</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Nabissi, Massimo" sort="Nabissi, Massimo" uniqKey="Nabissi M" first="Massimo" last="Nabissi">Massimo Nabissi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539026" status="INCOMING">
<orgName>School of Pharmacy, Department of Experimental Medicine</orgName>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-473150" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-473150" type="direct">
<org type="institution" xml:id="struct-473150" status="VALID">
<orgName>University of Camerino</orgName>
<date type="start">2016-11-24</date>
<desc>
<address>
<country key="IT"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Maurice, Tangui" sort="Maurice, Tangui" uniqKey="Maurice T" first="Tangui" last="Maurice">Tangui Maurice</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3068" status="VALID">
<idno type="RNSR">200716389N</idno>
<orgName>Mécanismes moléculaires dans les démences neurodégénératives</orgName>
<orgName type="acronym">MMDN</orgName>
<desc>
<address>
<addrLine>U1198 - Université de Montpellier, Place Eugène Bataillon 34095 Montpellier Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://mmdn.umontpellier.fr/fr/</ref>
</desc>
<listRelation>
<relation name="U1198" active="#struct-303623" type="direct"></relation>
<relation active="#struct-92690" type="direct"></relation>
<relation name="UMR_S 1198" active="#struct-410122" type="direct"></relation>
<relation active="#struct-110691" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="U1198" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-92690" type="direct">
<org type="institution" xml:id="struct-92690" status="OLD">
<orgName>Université Montpellier 2 - Sciences et Techniques</orgName>
<orgName type="acronym">UM2</orgName>
<date type="end">2014-12-31</date>
<desc>
<address>
<addrLine>Place Eugène Bataillon - 34095 Montpellier cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-montp2.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UMR_S 1198" active="#struct-410122" type="direct">
<org type="institution" xml:id="struct-410122" status="VALID">
<idno type="ISNI">0000000120970141</idno>
<orgName>Université de Montpellier</orgName>
<orgName type="acronym">UM</orgName>
<desc>
<address>
<addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.umontpellier.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-110691" type="direct">
<org type="institution" xml:id="struct-110691" status="VALID">
<orgName>École pratique des hautes études</orgName>
<orgName type="acronym">EPHE</orgName>
<desc>
<address>
<addrLine>4-14 Rue Ferrus, 75014 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.ephe.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Decker, Michael" sort="Decker, Michael" uniqKey="Decker M" first="Michael" last="Decker">Michael Decker</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-539025" status="INCOMING">
<orgName>Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy and Food Chemistry </orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-539024" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-539024" type="direct">
<org type="institution" xml:id="struct-539024" status="INCOMING">
<orgName>Julius Maximilian University</orgName>
<desc>
<address>
<country key="DE"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1021/acs.jmedchem.7b01760</idno>
<series>
<title level="j">Journal of Medicinal Chemistry</title>
<idno type="ISSN">0022-2623</idno>
<imprint>
<date type="datePub">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promisingtargets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE. A homology model for the hCB2R was developed based on the hCB1R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved hCB2R agonism. Unwanted μ-opioid receptor affinitycould be designed out. One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</title>
<author role="aut">
<persName>
<forename type="first">Dominik</forename>
<surname>Dolles</surname>
</persName>
<idno type="halauthorid">11241719</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Matthias</forename>
<surname>Hoffmann</surname>
</persName>
<idno type="halauthorid">485529</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Sandra</forename>
<surname>Gunesch</surname>
</persName>
<idno type="halauthorid">11241720</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Oliviero</forename>
<surname>Marinelli</surname>
</persName>
<idno type="halauthorid">11241721</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jan</forename>
<surname>Möller</surname>
</persName>
<idno type="halauthorid">11241722</idno>
<affiliation ref="#struct-539027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Giorgio</forename>
<surname>Santoni</surname>
</persName>
<idno type="halauthorid">11241723</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Arnaud</forename>
<surname>Chatonnet</surname>
</persName>
<email type="md5">6b15f2f43b384683aea44267aff7f6a3</email>
<email type="domain">inra.fr</email>
<idno type="halauthorid">1633671</idno>
<affiliation ref="#struct-206262"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Martin J.</forename>
<surname>Lohse</surname>
</persName>
<idno type="halauthorid">715442</idno>
<affiliation ref="#struct-539027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Hans-Joachim</forename>
<surname>Wittmann</surname>
</persName>
<idno type="halauthorid">575068</idno>
<affiliation ref="#struct-539028"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Andrea</forename>
<surname>Strasser</surname>
</persName>
<idno type="halauthorid">642133</idno>
<affiliation ref="#struct-539028"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Massimo</forename>
<surname>Nabissi</surname>
</persName>
<idno type="halauthorid">11241724</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Tangui</forename>
<surname>Maurice</surname>
</persName>
<email type="md5">1930fe38c793005f6531202464f7ad79</email>
<email type="domain">umontpellier.fr</email>
<idno type="idhal" notation="string">tangui-maurice</idno>
<idno type="idhal" notation="numeric">179841</idno>
<idno type="halauthorid">414464</idno>
<idno type="ORCID">https://orcid.org/0000-0002-4074-6793</idno>
<affiliation ref="#struct-3068"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Michael</forename>
<surname>Decker</surname>
</persName>
<idno type="halauthorid">11241725</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Archive Ouverte</forename>
<surname>ProdInra</surname>
</persName>
<email type="md5">32842db32e322d32df54caa7e75d71a2</email>
<email type="domain">inrae.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2018-07-12 20:32:11</date>
<date type="whenModified">2020-03-17 02:27:17</date>
<date type="whenReleased">2018-07-12 20:32:11</date>
<date type="whenProduced">2018</date>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="132775">
<persName>
<forename>Archive Ouverte</forename>
<surname>ProdInra</surname>
</persName>
<email type="md5">32842db32e322d32df54caa7e75d71a2</email>
<email type="domain">inrae.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-01837661</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-01837661</idno>
<idno type="halBibtex">dolles:hal-01837661</idno>
<idno type="halRefHtml">Journal of Medicinal Chemistry, American Chemical Society, 2018, 18 p. ⟨10.1021/acs.jmedchem.7b01760⟩</idno>
<idno type="halRef">Journal of Medicinal Chemistry, American Chemical Society, 2018, 18 p. ⟨10.1021/acs.jmedchem.7b01760⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="INRA">INRA - Institut national de la recherche agronomique</idno>
<idno type="stamp" n="EPHE">Ecole Pratique des Hautes Etudes</idno>
<idno type="stamp" n="BS">Biologie-Santé</idno>
<idno type="stamp" n="UNIV-MONTPELLIER">Université de Montpellier</idno>
<idno type="stamp" n="DMEM" corresp="UNIV-MONTPELLIER">Dynamique Musculaire Et Métabolisme</idno>
<idno type="stamp" n="MMDN">Mécanismes moléculaires dans les démences neurodégénératives</idno>
<idno type="stamp" n="PSL">Paris Sciences et Lettres (PSL) Research University</idno>
<idno type="stamp" n="TEST-DEV">TEST-DEV</idno>
<idno type="stamp" n="INRAE">Institut National de Recherche en Agriculture, Alimentation et Environnement</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="1">Not set</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</title>
<author role="aut">
<persName>
<forename type="first">Dominik</forename>
<surname>Dolles</surname>
</persName>
<idno type="halauthorid">11241719</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Matthias</forename>
<surname>Hoffmann</surname>
</persName>
<idno type="halauthorid">485529</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Sandra</forename>
<surname>Gunesch</surname>
</persName>
<idno type="halauthorid">11241720</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Oliviero</forename>
<surname>Marinelli</surname>
</persName>
<idno type="halauthorid">11241721</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jan</forename>
<surname>Möller</surname>
</persName>
<idno type="halauthorid">11241722</idno>
<affiliation ref="#struct-539027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Giorgio</forename>
<surname>Santoni</surname>
</persName>
<idno type="halauthorid">11241723</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Arnaud</forename>
<surname>Chatonnet</surname>
</persName>
<email type="md5">6b15f2f43b384683aea44267aff7f6a3</email>
<email type="domain">inra.fr</email>
<idno type="halauthorid">1633671</idno>
<affiliation ref="#struct-206262"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Martin J.</forename>
<surname>Lohse</surname>
</persName>
<idno type="halauthorid">715442</idno>
<affiliation ref="#struct-539027"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Hans-Joachim</forename>
<surname>Wittmann</surname>
</persName>
<idno type="halauthorid">575068</idno>
<affiliation ref="#struct-539028"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Andrea</forename>
<surname>Strasser</surname>
</persName>
<idno type="halauthorid">642133</idno>
<affiliation ref="#struct-539028"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Massimo</forename>
<surname>Nabissi</surname>
</persName>
<idno type="halauthorid">11241724</idno>
<affiliation ref="#struct-539026"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Tangui</forename>
<surname>Maurice</surname>
</persName>
<email type="md5">1930fe38c793005f6531202464f7ad79</email>
<email type="domain">umontpellier.fr</email>
<idno type="idhal" notation="string">tangui-maurice</idno>
<idno type="idhal" notation="numeric">179841</idno>
<idno type="halauthorid">414464</idno>
<idno type="ORCID">https://orcid.org/0000-0002-4074-6793</idno>
<affiliation ref="#struct-3068"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Michael</forename>
<surname>Decker</surname>
</persName>
<idno type="halauthorid">11241725</idno>
<affiliation ref="#struct-539025"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">15785</idno>
<idno type="issn">0022-2623</idno>
<idno type="eissn">1520-4804</idno>
<title level="j">Journal of Medicinal Chemistry</title>
<imprint>
<publisher>American Chemical Society</publisher>
<biblScope unit="pp">18 p.</biblScope>
<date type="datePub">2018</date>
</imprint>
</monogr>
<idno type="doi">10.1021/acs.jmedchem.7b01760</idno>
<idno type="prodinra">421333</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">
<p>The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promisingtargets for pharmacotherapy in the later stages of Alzheimer’s disease. We merged pharmacophores for both targets into small benzimidazole-based molecules, investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE. A homology model for the hCB2R was developed based on the hCB1R crystal structure and used for molecular dynamics studies to investigate binding modes. In vitro studies proved hCB2R agonism. Unwanted μ-opioid receptor affinitycould be designed out. One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement. The data shows the possibility to combine a small molecule with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000045 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000045 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:hal-01837661
   |texte=   Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021